WBI Investments LLC Lowers Stake in Universal Health Services, Inc. (NYSE:UHS)

WBI Investments LLC reduced its holdings in shares of Universal Health Services, Inc. (NYSE:UHS - Free Report) by 67.8% during the 4th quarter, according to its most recent 13F filing with the SEC. The fund owned 3,995 shares of the health services provider's stock after selling 8,409 shares during the period. WBI Investments LLC's holdings in Universal Health Services were worth $717,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. R Squared Ltd purchased a new position in Universal Health Services during the 4th quarter worth $29,000. Quent Capital LLC grew its position in Universal Health Services by 118.3% during the 4th quarter. Quent Capital LLC now owns 179 shares of the health services provider's stock worth $32,000 after purchasing an additional 97 shares during the last quarter. Campbell Capital Management Inc. acquired a new stake in shares of Universal Health Services in the 4th quarter worth $46,000. Huntington National Bank lifted its stake in shares of Universal Health Services by 55.6% in the 4th quarter. Huntington National Bank now owns 280 shares of the health services provider's stock worth $50,000 after acquiring an additional 100 shares during the period. Finally, Smartleaf Asset Management LLC lifted its stake in shares of Universal Health Services by 30.7% in the 4th quarter. Smartleaf Asset Management LLC now owns 455 shares of the health services provider's stock worth $81,000 after acquiring an additional 107 shares during the period. 86.05% of the stock is owned by hedge funds and other institutional investors.

Universal Health Services Stock Down 0.6%

Shares of NYSE UHS opened at $196.75 on Tuesday. The company has a quick ratio of 1.28, a current ratio of 1.39 and a debt-to-equity ratio of 0.69. Universal Health Services, Inc. has a 52 week low of $153.99 and a 52 week high of $243.25. The firm has a 50-day moving average price of $179.31 and a 200 day moving average price of $185.17. The stock has a market capitalization of $12.79 billion, a price-to-earnings ratio of 13.08, a price-to-earnings-growth ratio of 0.53 and a beta of 1.29.

Universal Health Services (NYSE:UHS - Get Free Report) last announced its earnings results on Monday, April 28th. The health services provider reported $4.84 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $4.36 by $0.48. Universal Health Services had a net margin of 6.66% and a return on equity of 15.75%. The company had revenue of $4.10 billion during the quarter, compared to analysts' expectations of $4.16 billion. During the same quarter in the previous year, the business posted $3.70 earnings per share. The firm's quarterly revenue was up 6.7% compared to the same quarter last year. Equities research analysts anticipate that Universal Health Services, Inc. will post 15.92 EPS for the current fiscal year.

Universal Health Services Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Monday, June 16th. Shareholders of record on Monday, June 2nd will be issued a $0.20 dividend. This represents a $0.80 annualized dividend and a dividend yield of 0.41%. The ex-dividend date of this dividend is Monday, June 2nd. Universal Health Services's dividend payout ratio (DPR) is presently 4.49%.

Wall Street Analyst Weigh In

Several research firms have recently commented on UHS. Stephens raised their target price on shares of Universal Health Services from $210.00 to $223.00 and gave the stock an "equal weight" rating in a research note on Friday, February 28th. Robert W. Baird restated a "neutral" rating and issued a $224.00 target price (down previously from $274.00) on shares of Universal Health Services in a research note on Tuesday, April 15th. Baird R W cut shares of Universal Health Services from a "strong-buy" rating to a "hold" rating in a research note on Tuesday, April 15th. Barclays raised their target price on shares of Universal Health Services from $249.00 to $257.00 and gave the stock an "overweight" rating in a research note on Tuesday, April 29th. Finally, Guggenheim began coverage on shares of Universal Health Services in a research note on Wednesday, April 9th. They issued a "buy" rating and a $208.00 target price for the company. Nine investment analysts have rated the stock with a hold rating and seven have issued a buy rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Hold" and an average price target of $224.77.

Insider Buying and Selling at Universal Health Services

In other Universal Health Services news, Director Maria Ruderman Singer sold 1,097 shares of the company's stock in a transaction dated Wednesday, May 14th. The shares were sold at an average price of $191.48, for a total value of $210,053.56. Following the sale, the director now owns 7,884 shares of the company's stock, valued at $1,509,628.32. This represents a 12.21% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 16.40% of the company's stock.

Universal Health Services Profile

Universal Health Services, Inc, through its subsidiaries, owns and operates acute care hospitals, and outpatient and behavioral health care facilities. It operates through Acute Care Hospital Services and Behavioral Health Care Services segments. The company's hospitals offer general and specialty surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic and coronary care, pediatric services, pharmacy services, and/or behavioral health services.

Want to see what other hedge funds are holding UHS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Universal Health Services, Inc. (NYSE:UHS - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.